demonstrated that a frameshift mutation in ZNF750, a zinc finger transcription factor and master regulator of epidermal differentiation, causes early onset (<10 years of age) autosomal dominant seborrhoea-like psoriasiform dermatitis with 100% penetrance (OMIM #610227). Yet, how ZNF750 dysfunction causes the SD phenotype remains unknown.
We have previously generated knockout mice to determine MPZL3 (myelin protein zero-like 3) function in the skin. Mpzl3 encodes an immunoglobulin protein and is expressed in the suprabasal layers of mouse epidermis, the sebaceous gland and anagen hair follicles. 3, 4 Not surprisingly, Mpzl3 knockout mice showed various skin abnormalities, including epidermal and sebaceous hyperplasia and hair loss. [3] [4] [5] Interestingly, these mice also developed early onset skin inflammation with dandrufflike flakes. 4 Importantly, ZNF750 was recently shown to directly bind to MPZL3 promoter and activate its transcription in cultured human keratinocytes. 6 Therefore, Mpzl3 knockout mice can serve as a useful model to understand SD pathogenesis caused by ZNF750 dysfunction.
| QUESTIONS ADDRESSED
In this study, we further investigated the inflammatory skin phenotype of Mpzl3 knockout mice to better understand the pathobiology of SD.
| EXPERIMENTAL DESIGN
See Supporting Information.
| RESULTS
To investigate the effects of loss of MPZL3 function in skin Interestingly, spongiosis was not detected in the family with SD and the ZNF750 mutation.
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Prior to apparent skin inflammation, significant levels of aberrant keratin 6 expression were already detected in the hyperplastic epidermis of Mpzl3 −/− mice 12 days after birth (P12) (Fig. S1 ). Expression of filaggrin was also increased in Mpzl3 −/− epidermis (Fig. 1p,q) . PCNA immunohistochemistry demonstrated increased basal cell proliferation in Mpzl3 −/− epidermis (Fig. 1r,s) . We also detected MPZL3 protein expression in the granular layers of human epidermis (Fig. 1u) , consistent with previous reports in mouse (Fig. 1t ) 4 and human skin. Toluidine blue permeability assay detected increased dye permeability of Mpzl3 −/− skin, suggestive of a defective epidermal barrier (Fig. 2k,l Increased toluidine blue dye permeability in E17.0 Mpzl3 −/− embryos changes in genes related to barrier function and inflammation (Table   S1 ), including small proline-rich protein (Sprr) genes, keratins 6 and 16, inflammatory mediators and antimicrobial peptides (defensins and lipocalin), chemokines (ccls) and inflammatory cytokines and receptors (interleukins and receptors) (Table S1 ) [S1-S3]. These observations suggest a twofold consequence of loss of MPZL3 function in the skin: defective barrier and recruitment of immune cells.
| CONCLUSIONS
In this study, we demonstrated seborrhoeic dermatitis-like clinical features with associated histology in the Mpzl3 knockout mice. Mpzl3 
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Figure S1 (a-f) Significant levels of aberrant keratin 6 expression was detected in Mpzl3-/-epidermis as early as 12 days after birth (d).
Appendix S1 Supplementary Materials and Methods
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(g-j) We did not detect significant differences in cytotoxic T cell (CD8 positive) and B cell (CD19 positive) infiltrates between Mpzl3 -/-skin (h, j) and +/-eyelids (g, i)
Table S1 Gene expression analysis by microarray indicated that loss of MPZL3 function caused altered epidermal differentiation and increased inflammatory response in the skin (P9)
